Narcostart (Sedastart) 1 mg/ml solution for injection for cats and dogs
Narcostart (Sedastart) 1 mg/ml solution for injection for cats and dogs
Authorised
- Medetomidine hydrochloride
Product identification
Medicine name:
Narcostart (Sedastart) 1 mg/ml solution for injection for cats and dogs
Narcostart 1 mg/ml oplossing voor injectie voor honden en katten
Narcostart 1 mg/ml Solution injectable pour chats et chiens
Narcostart 1 mg/ml Injektionslösung für Hunde und Katzen
Active substance:
- Medetomidine hydrochloride
Target species:
-
Dog
-
Cat
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Medetomidine hydrochloride1.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Dog
- Cat
-
Intravenous use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM91
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- 1 x 1 glass vial with 10 ml. Glass (type I) vials closed with bromobutyl rubber closures secured with aluminium crimp caps.
- 5 x 1 glass vial with 10 ml. Glass (type I) vials closed with bromobutyl rubber closures secured with aluminium crimp caps.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Le Vet. B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Produlab Pharma B.V.
- Eurovet Animal Health B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0138/001
Concerned member states:
-
Austria
-
Belgium
-
Czechia
-
Denmark
-
Finland
-
France
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Luxembourg
-
Poland
-
Portugal
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 3/06/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?:
